Axon price target raised to $310 from $300 at Baird

Baird raised the firm’s price target on Axon to $310 from $300 and keeps an Outperform rating on the shares. The firm said they reported strong Q4 results, including solid upside to revenue and margins, with revenue upside driven by Taser 10. Initial 2024 revenue guidance growth exceeded prior estimates and consensus at the midpoint.